Molecule Details
InChIKeyITJNARMNRKSWTA-UHFFFAOYSA-N
Compound NameNisoxetine
Canonical SMILESCNCCC(Oc1ccccc1OC)c1ccccc1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL7.25
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB09186
Drug NameNisoxetine
CAS Number53179-07-0
Groups experimental
ATC Codes nan
DescriptionNisoxetine is a selective norepinephrine reuptake inhibitor (SNRI) developed in the 1970s. It was originally investigated as an antidepressant but has no current clinical applications aside from being a research standard SNRI. It has been used to research obesity and energy balance, and exerts some ...

Categories: Adrenergic Uptake Inhibitors Amines Antidepressive Agents Central Nervous System Depressants Norepinephrine, antagonists & inhibitors Propylamines
Cross-references: BindingDB: 22417 ChEBI: 73410 CHEMBL295467 ChemSpider: 4344 D05173 PubChem:4500 PubChem:310265094 Wikipedia: Nisoxetine
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P23975 SLC6A2 Homo sapiens Human PF00209 8.1 IC50 ChEMBL;BindingDB
Q01959 SLC6A3 Homo sapiens Human PF00209 7.1 Ki ChEMBL;BindingDB
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 6.6 IC50 ChEMBL;BindingDB
DrugBank Target Actions (3)
Target Gene Target Name Action Type
P23975 SLC6A2 Sodium-dependent noradrenaline transporter inhibitor targets
P31645 SLC6A4 Sodium-dependent serotonin transporter inhibitor targets
Q01959 SLC6A3 Sodium-dependent dopamine transporter inhibitor targets